Raleigh Capital Management’s Ocugen OCGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-10,550
Closed -$8.49K 882
2024
Q4
$8.49K Buy
+10,550
New +$9.66K ﹤0.01% 627
2024
Q3
Sell
-22,500
Closed -$34.9K 1041
2024
Q2
$34.9K Buy
22,500
+2,500
+13% +$3.9K 0.01% 348
2024
Q1
$32.8K Buy
+20,000
New +$16.8K 0.01% 360

Other funds holding OCGN

Raleigh Capital Management's OCGN Position: Q1 2025 in Review

Raleigh Capital Management sold out of Ocugen (OCGN) in Q1 2025, closing a stake of 10,550 shares — an estimated $8.49K sold.

Raleigh Capital Management first reported a position in OCGN in Q1 2024 and held it in 3 quarters. The position peaked at $34.9K in Q2 2024. 110 funds tracked by Wall St. Rank hold OCGN as of Q1 2025.

  • Raleigh Capital Management reported no remaining Ocugen position as of Q1 2025 after selling out during the quarter.
  • Raleigh Capital Management sold 10,550 Ocugen shares in Q1 2025, an estimated $8.49K.
  • Raleigh Capital Management first reported a position in Ocugen in Q1 2024 and held it in 3 quarters.
  • Raleigh Capital Management's Ocugen position peaked at $34.9K in Q2 2024.
  • 110 funds tracked by Wall St. Rank held Ocugen as of Q1 2025.

Based on Raleigh Capital Management's 13F filing for Q1 2025, filed 29 Apr 2025.